JNJ-64619178, a selective and pseudo-irreversible PRMT5 inhibitor with potent in vitro and in vivo activity, demonstrated in several lung cancer modelsTongfei Wu,Hillary Millar,Dana Gaffney,Lijs Beke,Geert Mannens,Petra Vinken,Ivan Sommers,Jan-Willem Thuring,Weimei Sun,Christopher Moy,Vineet Pande,Junguo Zhou,Nahor Haddish-Berhane, Mark Salvati,Sylvie Laquerre,Matthew V. Lorenzi,Dirk BrehmerCANCER RESEARCH(2018)引用 22|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要